solo para uso en investigación
Cat. No.: S1155
| Dianas relacionadas | EGFR JAK Pim |
|---|---|
| Otros STAT Inhibidores | Napabucasin (BBI608) Stattic Cryptotanshinone (Tanshinone C) C188-9 (TTI-101) SH-4-54 BP-1-102 AS1517499 HO-3867 Nifuroxazide Homoharringtonine (HHT) |
| Líneas celulares | Tipo de ensayo | Concentración | Tiempo de incubación | Formulación | Descripción de la actividad | PMID |
|---|---|---|---|---|---|---|
| U87 | Growth Inhibition Assay | 72 h | IC50=55.1 μM | 20072652 | ||
| U373 | Growth Inhibition Assay | 72 h | IC50=52.5 μM | 20072652 | ||
| HPAC | Growth Inhibition Assay | 72 h | IC50>100 μM | 20072652 | ||
| PANC-1 | Growth Inhibition Assay | 72 h | IC50>100 μM | 20072652 | ||
| SK-BR-3 | Growth Inhibition Assay | 72 h | IC50>100 μM | 20072652 | ||
| U-373 MG | Cytotoxicity Assay | 3/10 μM | 24 h | reduces FN-γ-induced cell neurotoxicity | 20888416 | |
| MDA-MB-231 | Growth Inhibition Assay | 72 h | IC50>100 μM | 20072652 | ||
| HUVEC | Function Assay | 0.5-20 μM | 24 h | DMSO | suppresses the hypoxia-induced accumulation of HIF-1α | 21523559 |
| Huh7 | Growth Inhibition Assay | 100 nM | 48 h | DMSO | inhibits the IL-6 stimulation promoted cell proliferation | 23364389 |
| PLC/PRF/5 | Growth Inhibition Assay | 100 nM | 48 h | DMSO | inhibits the IL-6 stimulation promoted cell proliferation | 23364389 |
| H460 | Function Assay | 50/100 μM | 48 h | inhibits the Stat3C increased miR-92a expression | 23820254 | |
| H1299 | Function Assay | 50/100 μM | 48 h | suppresses miR-92a expression dose-dependently | 23820254 | |
| T-cell | Growth Inhibition Assay | IC50=50 μM | 24068731 | |||
| U373 | Growth Inhibition Assay | 125 μM | 24 h | DMSO | disrupts STAT3 signaling and proliferation | 24070820 |
| HUT-102 | Apoptosis Assay | 75-300 μM | 24/48 h | suppresses cell proliferation in a dose-dependent manner and induces cell apoptosis | 24090995 | |
| MT-2 | Apoptosis Assay | 75-300 μM | 24/48 h | suppresses cell proliferation in a dose-dependent manner and induces cell apoptosis | 24090995 | |
| H460 | Apoptosis Assay | 100 nM | 24 h | enhances cell death co-treated with LY294002 | 24472538 | |
| A459 | Apoptosis Assay | 100 nM | 24 h | induces cell apoptosis co-treated with BEZ235 | 24472538 | |
| H460 | Apoptosis Assay | 100 nM | 24 h | induces cell apoptosis co-treated with BEZ235 | 24472538 | |
| GC | Growth Inhibition Assay | 50-125 μM | 72 h | attenuates the cell growth in a dose-dependent manner | 25774503 | |
| GH3 | Growth Inhibition Assay | 50-125 μM | 72 h | attenuates the cell growth in a dose-dependent manner | 25774503 | |
| BT474R | Function Assay | 50 μM | 10-60 d | inhibits STAT3 activity | 25327561 | |
| NCI-N87R | Function Assay | 50 μM | 10-60 d | inhibits STAT3 activity | 25327561 | |
| MDA-MB-468 | Function assay | 100 uM | 24 hrs | Inhibition of Stat3 activation in human MDA-MB-468 cells at 100 uM after 24 hrs | 17463090 | |
| MDA-MB-435 | Function assay | 100 uM | 24 hrs | Inhibition of Stat3 activation in human MDA-MB-435 cells at 100 uM after 24 hrs | 17463090 | |
| MDA-MB-231 | Function assay | 100 uM | 24 hrs | Inhibition of Stat3 activation in human MDA-MB-231 cells at 100 uM after 24 hrs | 17463090 | |
| NIH3T3 | Function assay | 100 uM | 24 hrs | Reduction of pTyr-705 Stat3 level in v-Src expressing mouse NIH3T3 cells at 100 uM after 24 hrs | 17463090 | |
| NIH3T3 | Growth inhibition assay | 100 uM | 4 days | Growth inhibition of mouse NIH3T3 cells expressing v-Src at 100 uM after 4 days by trypan blue exclusion assay | 17463090 | |
| MDA-MB-435 | Growth inhibition assay | 100 uM | 4 days | Growth inhibition of human MDA-MB-435 cells expressing v-Src at 100 uM after 4 days by trypan blue exclusion assay | 17463090 | |
| MDA-MB-231 | Growth inhibition assay | 100 uM | 4 days | Growth inhibition of human MDA-MB-231 cells expressing v-Src at 100 uM after 4 days by trypan blue exclusion assay | 17463090 | |
| MDA-MB-468 | Growth inhibition assay | 100 uM | 4 days | Growth inhibition of human MDA-MB-468 cells expressing v-Src at 100 uM after 4 days by trypan blue exclusion assay | 17463090 | |
| NIH3T3 | Growth inhibition assay | 100 uM | Growth inhibition of mouse NIH3T3 cells expressing v-Ras at 100 uM for every 3 days by soft-agar colony-formation assay | 17463090 | ||
| MDA-MB-435 | Apoptosis assay | 30 to 100 uM | 48 hrs | Induction of apoptosis in human MDA-MB-435 cells expressing active Stat3 at 30 to 100 uM after 48 hrs | 17463090 | |
| MDA-MB-231 | Apoptosis assay | 100 uM | 24 hrs | Reduction of apoptosis in Stat3 transfected human MDA-MB-231 cells at 100 uM after 24 hrs | 17463090 | |
| MDA-MB-231 | Function assay | 100 uM | 48 hrs | Reduction of cyclin D1 gene expression in human MDA-MB-231 cells at 100 uM after 48 hrs | 17463090 | |
| MDA-MB-231 | Apoptosis assay | 100 uM | 24 hrs | Induction of apoptosis in Stat3 SH2 domain transfected human MDA-MB-231 cells at 100 uM after 24 hrs | 17463090 | |
| MDA-MB-231 | Apoptosis assay | 100 uM | 24 hrs | Induction of apoptosis in Stat3C transfected human MDA-MB-231 cells at 100 uM after 24 hrs | 17463090 | |
| NIH3T3 | Function assay | 100 uM | 48 hrs | Reduction of cyclin D1 gene expression in v-Src transfected mouse NIH3T3 cells at 100 uM after 48 hrs | 17463090 | |
| NIH3T3 | Function assay | 100 uM | 48 hrs | Reduction of Bcl-xL gene expression in v-Src transfected mouse NIH3T3 cells at 100 uM after 48 hrs | 17463090 | |
| NIH3T3 | Function assay | 100 uM | 48 hrs | Reduction of survivin gene expression in v-Src transfected mouse NIH3T3 cells at 100 uM after 48 hrs | 17463090 | |
| MDA-MB-231 | Function assay | 100 uM | 48 hrs | Reduction of Bcl-xL gene expression in human MDA-MB-231 cells at 100 uM after 48 hrs | 17463090 | |
| MDA-MB-231 | Function assay | 100 uM | 48 hrs | Reduction of survivin gene expression in human MDA-MB-231 cells at 100 uM after 48 hrs | 17463090 | |
| MDA-MB-231 | Antitumor assay | 5 mg/kg | 2 weeks | Antitumor activity against human MDA-MB-231 cells expressing active Stat3 xenografted in mouse at 5 mg/kg, iv for every 3 days for 2 weeks | 17463090 | |
| NIH3T3 | Growth inhibition assay | 100 uM | Growth inhibition of mouse NIH3T3 cells expressing v-Src at 100 uM for every 3 days by soft-agar colony-formation assay | 17463090 | ||
| A673 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 29435139 | |||
| SK-N-MC | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 29435139 | |||
| NB1643 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 29435139 | |||
| LAN-5 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 29435139 | |||
| Haga clic para ver más datos experimentales de líneas celulares | ||||||
| Peso molecular | 365.36 | Fórmula | C16H15NO7S |
Almacenamiento (Desde la fecha de recepción) | |
|---|---|---|---|---|---|
| Nº CAS | 501919-59-1 | Descargar SDF | Almacenamiento de soluciones madre |
|
|
|
In vitro |
DMSO
: 73 mg/mL
(199.8 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Paso 1: Introduzca la información a continuación (Recomendado: Un animal adicional para tener en cuenta la pérdida durante el experimento)
Paso 2: Introduzca la formulación in vivo (Esto es solo la calculadora, no la formulación. Por favor, contáctenos primero si no hay una formulación in vivo en la sección de Solubilidad.)
Resultados del cálculo:
Concentración de trabajo: mg/ml;
Método para preparar el líquido maestro de DMSO: mg fármaco predissuelto en μL DMSO ( Concentración del líquido maestro mg/mL, Por favor, contáctenos primero si la concentración excede la solubilidad del DMSO del lote del fármaco. )
Método para preparar la formulación in vivo: Tomar μL DMSO líquido maestro, luego añadirμL PEG300, mezclar y clarificar, luego añadirμL Tween 80, mezclar y clarificar, luego añadir μL ddH2O, mezclar y clarificar.
Método para preparar la formulación in vivo: Tomar μL DMSO líquido maestro, luego añadir μL Aceite de maíz, mezclar y clarificar.
Nota: 1. Por favor, asegúrese de que el líquido esté claro antes de añadir el siguiente disolvente.
2. Asegúrese de añadir el (los) disolvente(s) en orden. Debe asegurarse de que la solución obtenida, en la adición anterior, sea una solución clara antes de proceder a añadir el siguiente disolvente. Se pueden utilizar métodos físicos como el vórtice, el ultrasonido o el baño de agua caliente para ayudar a la disolución.
| Características |
A chemical probe inhibitor of Stat3 activity.
|
|---|---|
| Targets/IC50/Ki |
STAT3
(Cell-free assay) 86 μM
|
| In vitro |
NSC 74859 (S3I-201) inhibits growth and induces apoptosis preferentially in tumor cells that contain persistently activated Stat3 by inhibiting Stat3·Stat3 complex formation and Stat3 DNA-binding and transcriptional activities. Moreover, it also inhibits the expression of the Stat3-regulated genes encoding cyclin D1, Bcl-xL, and survivin.This compound inhibits breast carcinoma MDA-MB-435, MDA-MB-453 and MDA-MB-231 cell lines with IC50 of 100 μM. In addition, the cells with impaired TGF-β signaling are four times as sensitive to S3I-201.A recent study shows that it potentiates the antiproliferative effect in HepG2 and Huh-7 cells via the STAT3 signalling pathway. |
| Ensayo de quinasa |
Ensayo de unión de STAT3 al ADN in vitro y análisis EMSA
|
|
Brevemente, se añaden 100 µL de biotinil-e-Ac-EPQpYEEIEL-OH (en 50 mM Tris/150 mM NaCl, pH 7,5) a cada pocillo de placas de microtitulación de 96 pocillos recubiertas de estreptavidina y se incuban con agitación a 4 °C durante la noche. Luego, las placas se enjuagan con PBS/Tween 20 y luego dos veces con 200 µL de BSA-T-PBS (0,2 % BSA/0,1 % Tween 20/PBS). Luego se añaden 50 µL de proteína de fusión Lck-SH2-GST (6,4 ng/ml en BSA-T-PBS) a cada pocillo de la placa de 96 pocillos en presencia y ausencia de 50 µL de NSC 74859 (S3I-201) (para concentraciones finales de 30 y 100 mM), y la placa se agita a temperatura ambiente durante 4 horas. Después de retirar las soluciones, cada pocillo se enjuaga cuatro veces con BSA-T-PBS (200 µL), y se añaden 100 µL de anticuerpo policlonal de conejo anti-GST (100 ng/mL en BSA-T-PBS) a cada pocillo y se incuba a 4 °C durante la noche. Después de lavar con BSA-T-PBS, se añaden 100 µL de anticuerpo de ratón anti-conejo conjugado con peroxidasa de rábano picante (200 ng/mL en BSA-T-PBS) a cada pocillo y se incuban durante 45 minutos a temperatura ambiente. Después de cuatro pasos de lavado con BSA-T-PBS y tres pasos de lavado con PBS-T, se añaden 100 µL de sustrato de peroxidasa a cada pocillo y se incuban durante 5-15 minutos. La reacción de peroxidasa se detiene añadiendo 100 µL de solución de ácido sulfúrico 1 M, y la absorbancia se lee a 450 nm con un lector de placas ELISA.
|
|
| In vivo |
NSC 74859 (S3I-201) (5 mg/kg, i.v. every 2 or every 3 days) shows the antitumor efficacy in mouse models with human breast tumor xenografts that harbor constitutively active Stat3.This compound treatment reduces Varicella-zoster virus (VZV) replication on the basis of the bioluminescence signal and the number of positive skin xenografts compared with DMSO-treated mice by inhibiting STAT3 phosphorylation. |
Referencias |
|
| Métodos | Biomarcadores | Imágenes | PMID |
|---|---|---|---|
| Western blot | STAT3 / p-STAT3 / Cyclin D1 / Bcl-2 / Nanog / OCT4 / ALDH1 / CD44 PD-L1 |
|
26556875 |
| Immunofluorescence | p-STAT3 Oct4 / Twist |
|
26556875 |
| Growth inhibition assay | Cell viability |
|
26813676 |